• About Us
    • Our People + Values
    • Manufacturing
  • Research + Development
  • Patients + Families
    • Understanding SMA
    • Managed Access Program
    • Patient Resources
  • HealthcareProfessionals
    • Research Grants
    • Medical Education Grants
  • Careers
  • Media
  • Transparency+ Disclosure

极光加速3.0

AveXis is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases.

极光加速3.0

Jun 01, 2023

AveXis Community Statement on Global Managed Access Program for AVXS-101